B. Kis et al., Pituitary adenylate cyclase-activating polypeptide inhibits the cyclooxygenase pathway of rat cerebral microvessels, ACT PHYSL S, 167(1), 1999, pp. 43-47
The presence of nerve endings containing pituitary adenylate cyclase-activa
ting polypeptide (PACAP) and vasoactive intestinal polypeptide (VIP) around
cerebral microvessels suggests that these peptides have regulatory roles i
n the cerebral microcirculation. Prostanoids synthesized by the cerebrovasc
ular endothelium have a determining role in the regulation of the brain cir
culation. In the present study, the effects of PACAP and VIP on the cycloox
ygenase pathway of cerebral microvessels were investigated. The isolated mi
crovessels were incubated with 1-C-14-arachidonic acid and different concen
trations of the peptides. The prostanoids formed were separated by means of
overpressure thin-layer chromatography, and were quantitatively determined
by liquid scintillation. Higher concentrations (10(-7) and 10(-6) mol L-1)
of PACAP significantly inhibited the activity of the cyclooxygenase pathwa
y, whereas VIP had no significant effect on it. As regards the cyclooxygena
se metabolites, the syntheses of thromboxane Ag and prostaglandin Dp were i
nhibited significantly. PACAP and VIP are known to increase the intracellul
ar cAMP level in the cerebral microvessels and in the present experiments t
he protein kinase A inhibitor H-89 attenuated the effect of PACAP on prosta
noid synthesis. It is concluded that the cyclooxygenase pathway of rat cere
bral microvessels is more sensitive to PACAP than to VIP. The inhibitory ef
fect of PACAP on prostanoid synthesis is mediated via a cAMP-dependent path
way. By inhibiting the formation of vasoactive prostanoids, PACAP can decre
ase the vasoreactivity of the microvessels.